Full bill text rendering is coming soon.
In the meantime, read the full text on Congress.gov ↗.
HR 10858 — 119th Congress
Authorizes grants to state, local, tribal, and nongovernmental health entities to research best practices for blood cancer awareness and education, with priority given to communities with high blood cancer rates or significant mortality.
Creates a new federal program to coordinate blood cancer awareness, health professional education, and patient support across federal agencies including the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and Health Resources and Services Administration (HRSA).
Authorizes grants to universities and academic medical centers to research improved diagnostics, novel treatments, risk factors, and genetic predisposition screening for blood cancer, aiming to expand access to early detection and care.
No possible riders have been surfaced for this bill.
This bill creates the National Blood Cancer Program (NBCP) within the Department of Health and Human Services (HHS). The NBCP would coordinate efforts across federal agencies to improve public awareness, train health professionals, and support blood cancer patients and caregivers. It would fund grants for research on education and awareness, as well as grants to universities and medical centers to improve diagnosis and treatment access, with annual reports required to Congress.
AI-generated summary, pending human review.
Full bill text rendering is coming soon.
In the meantime, read the full text on Congress.gov ↗.
| Version | Event | Date | User support | Your vote | Roll calls |
|---|---|---|---|---|---|
| Original |
Initial publication
Oct 22, 2026
|
Oct 22, 2026 | No votes yet | — | — |
Authorizes grants to state, local, tribal, and nongovernmental health entities to research best practices for blood cancer awareness and education, with priority given to communities with high blood cancer rates or significant mortality.
Funding / Appropriations
Creates a new federal program to coordinate blood cancer awareness, health professional education, and patient support across federal agencies including the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and Health Resources and Services Administration (HRSA).
Core Policy Mechanism
Authorizes grants to universities and academic medical centers to research improved diagnostics, novel treatments, risk factors, and genetic predisposition screening for blood cancer, aiming to expand access to early detection and care.
Funding / Appropriations
You have not made a selection on all required items:
Choose Neutral if you prefer not to commit. Leaving without completing will remove all your votes for this bill from the totals.
You have already recommended the maximum number of components allowed on this bill. To recommend [new component], choose one of your current recommendations to unselect: